| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in the treatment of hepatitis C in children and adolescents
|
McLin, Valérie A.
|
|
|
|
3 |
p. 97-103
|
artikel
|
| 2 |
Alcohol abuse and chronic hepatitis C
|
Nguyen, Tom
|
|
2007
|
|
3 |
p. 119-124
|
artikel
|
| 3 |
Antiviral therapy as an adjunct to passive-active immunotherapy for prevention of perinatal transmission of HBV
|
TenCate, Veronica
|
|
2009
|
|
3 |
p. 87-88
|
artikel
|
| 4 |
Baseline and On-treatment Predictors of Chronic Hepatitis B Patients Receiving Pegylated Interferon Therapy in Asia
|
Charatcharoenwitthaya, Phunchai
|
|
2013
|
|
3 |
p. 165-173
|
artikel
|
| 5 |
Chemoprevention of Patients with Hepatitis B Receiving Chemotherapy or Bone Marrow Transplant
|
Gopal, Kavitha
|
|
2010
|
|
3 |
p. 178-186
|
artikel
|
| 6 |
Chronic hepatitis C in the Latino population
|
Rodríguez-Torres, Maribel
|
|
2008
|
|
3 |
p. 106-112
|
artikel
|
| 7 |
Cyclophilin Inhibitors
|
Flisiak, Robert
|
|
|
|
3 |
p. 153-159
|
artikel
|
| 8 |
Cyclophilin Inhibitors
|
Flisiak, Robert
|
|
2012
|
|
3 |
p. 153-159
|
artikel
|
| 9 |
Hepatitis B and pregnancy
|
Tran, Tram T.
|
|
2009
|
|
3 |
p. 91-95
|
artikel
|
| 10 |
Hepatitis B virus reactivation in association with antineoplastic therapy
|
Yeo, Winnie
|
|
2009
|
|
3 |
p. 127-133
|
artikel
|
| 11 |
Hepatitis C After Liver Transplantation: Treatment and Impact on Patient and Graft Survival
|
Kemmer, Nyingi M.
|
|
2010
|
|
3 |
p. 161-168
|
artikel
|
| 12 |
Hepatitis C and hepatocellular carcinoma
|
Leach, Benjamin H.
|
|
2007
|
|
3 |
p. 87-90
|
artikel
|
| 13 |
Hepatitis C in correctional institutions
|
Zaller, Nickolas D.
|
|
2007
|
|
3 |
p. 114-118
|
artikel
|
| 14 |
Hepatitis C in patients with chronic kidney disease: Course and management
|
Whang, Charles S.
|
|
2007
|
|
3 |
p. 96-102
|
artikel
|
| 15 |
Hepatitis C Therapy: Lessons of the Last Two Decades
|
Tanwar, Sudeep
|
|
2012
|
|
3 |
p. 119-127
|
artikel
|
| 16 |
Hepatitis C viral kinetics in special populations
|
Dahari, Harel
|
|
2008
|
|
3 |
p. 97-105
|
artikel
|
| 17 |
Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and Interleukin-28B
|
Dahari, Harel
|
|
2011
|
|
3 |
p. 214-227
|
artikel
|
| 18 |
Hepatitis C Virus and End Stage Renal Disease
|
Gutierrez, Julio A.
|
|
2011
|
|
3 |
p. 196-203
|
artikel
|
| 19 |
Hepatitis C Virus and Innate Immunity: Taking a Fresh Look into an Old Issue
|
Seetharam, Anil
|
|
2011
|
|
3 |
p. 186-195
|
artikel
|
| 20 |
Hepatitis C Virus and Statins: Is There a Role?
|
Campo, José A. Del
|
|
2011
|
|
3 |
p. 162-167
|
artikel
|
| 21 |
HIV and coinfected patients
|
Vachon, Marie-Louise
|
|
2009
|
|
3 |
p. 103-110
|
artikel
|
| 22 |
HIV and HCV Coinfection: Where Are We in 2010?
|
Schaefer, Esperance
|
|
2010
|
|
3 |
p. 155-160
|
artikel
|
| 23 |
HIV and HCV Coinfection: Where Are We in 2010?
|
Schaefer, Esperance
|
|
|
|
3 |
p. 155-160
|
artikel
|
| 24 |
IL28B: Current and Future Use
|
Mei, S. G. Chen Yi
|
|
2012
|
|
3 |
p. 136-145
|
artikel
|
| 25 |
IL28B Genotype on HCV Infection in Asia
|
Liu, Chen-Hua
|
|
2013
|
|
3 |
p. 149-156
|
artikel
|
| 26 |
IL28B: Implications for Therapy
|
Mufti, Arjmand R.
|
|
2011
|
|
3 |
p. 153-161
|
artikel
|
| 27 |
Impact of Ethnicity and Race on Treatment Response: Past, Present and Future
|
Rodríguez-Torres, Maribel
|
|
2012
|
|
3 |
p. 128-135
|
artikel
|
| 28 |
Impact of obesity, hepatic steatosis, and insulin resistance on hepatitis C treatment outcomes
|
Elgouhari, Hesham M.
|
|
2008
|
|
3 |
p. 127-133
|
artikel
|
| 29 |
Iron and Hepatitis C
|
Narang, Tarun K.
|
|
2010
|
|
3 |
p. 169-177
|
artikel
|
| 30 |
Management of HBV, HCV, and HDV coinfection
|
Mendizabal, Manuel
|
|
2009
|
|
3 |
p. 111-118
|
artikel
|
| 31 |
Management of hepatitis B in patients with HBeAg-negative disease
|
Ayoub, Walid S.
|
|
2007
|
|
3 |
p. 91-95
|
artikel
|
| 32 |
Metabolic Syndrome and HCV: Where Do We Stand in 2010?
|
Lamb, Paul
|
|
2010
|
|
3 |
p. 133-139
|
artikel
|
| 33 |
Molecular Epidemiology of HCV in Asia
|
Wei, Lai
|
|
2013
|
|
3 |
p. 133-142
|
artikel
|
| 34 |
New and Evolving Management Paradigms for Hepatitis C after Liver Transplantation
|
Barritt, A. Sidney
|
|
2011
|
|
3 |
p. 179-185
|
artikel
|
| 35 |
Non-interferon Therapies for Hepatitis C
|
Membreno, Fernando E.
|
|
|
|
3 |
p. 146-152
|
artikel
|
| 36 |
Non-interferon Therapies for Hepatitis C
|
Membreno, Fernando E.
|
|
2012
|
|
3 |
p. 146-152
|
artikel
|
| 37 |
NS5A Inhibitors
|
O’Brien, Christopher
|
|
2012
|
|
3 |
p. 181-187
|
artikel
|
| 38 |
Nucleos(t)ide Analogues Therapy for Chronic Hepatitis B in Taiwan: Short-Term Versus Long-Term
|
Peng, Cheng-Yuan
|
|
2013
|
|
3 |
p. 181-187
|
artikel
|
| 39 |
Pathogenesis and natural course of hepatic steatosis and insulin resistance in patients with hepatitis C
|
Romero-Gómez, Manuel
|
|
2008
|
|
3 |
p. 113-119
|
artikel
|
| 40 |
Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response
|
Chak, Eric
|
|
2010
|
|
3 |
p. 147-154
|
artikel
|
| 41 |
Resistance to Direct-Acting Antivirals
|
Pawlotsky, Jean-Michel
|
|
2012
|
|
3 |
p. 188-194
|
artikel
|
| 42 |
Ribavirin: How Does it Work and is it Still Needed?
|
Bunchorntavakul, Chalermrat
|
|
2011
|
|
3 |
p. 168-178
|
artikel
|
| 43 |
Ribavirin: How Does it Work and is it Still Needed?
|
Bunchorntavakul, Chalermrat
|
|
|
|
3 |
p. 168-178
|
artikel
|
| 44 |
Second Generation Protease Inhibitors and Nucleotide Inhibitors
|
Jafri, Syed-Mohammad
|
|
|
|
3 |
p. 172-180
|
artikel
|
| 45 |
Second Generation Protease Inhibitors and Nucleotide Inhibitors
|
Jafri, Syed-Mohammad
|
|
2012
|
|
3 |
p. 172-180
|
artikel
|
| 46 |
Telaprevir and Boceprevir: The Future Is Now
|
Calle Serrano, Beatriz
|
|
|
|
3 |
p. 160-171
|
artikel
|
| 47 |
Telaprevir and Boceprevir: The Future Is Now
|
Calle Serrano, Beatriz
|
|
2012
|
|
3 |
p. 160-171
|
artikel
|
| 48 |
Tertiary Prevention of HBV-related HCC in Asia
|
Wong, Grace Lai-Hung
|
|
|
|
3 |
p. 157-164
|
artikel
|
| 49 |
Tertiary Prevention of HBV-related HCC in Asia
|
Wong, Grace Lai-Hung
|
|
2013
|
|
3 |
p. 157-164
|
artikel
|
| 50 |
The Evolution of HCV Treatment in Taiwan
|
Huang, Chung-Feng
|
|
2013
|
|
3 |
p. 143-148
|
artikel
|
| 51 |
The Role of HBsAg Quantification in the Natural Course of HBV Infection in Asia
|
Chen, Yi-Cheng
|
|
2013
|
|
3 |
p. 174-180
|
artikel
|
| 52 |
Treatment of chronic hepatitis B virus infection in children
|
Brumbaugh, David E.
|
|
2009
|
|
3 |
p. 96-102
|
artikel
|
| 53 |
Treatment of Chronic Hepatitis C in the Age of Direct-Acting Antivirals with Emphasis on First Generation Inhibitors of HCV NS3/4A Protease
|
Truesdale, Aimee E.
|
|
2011
|
|
3 |
p. 204-213
|
artikel
|
| 54 |
Treatment of Chronic Hepatitis C in the Age of Direct-Acting Antivirals with Emphasis on First Generation Inhibitors of HCV NS3/4A Protease
|
E. Truesdale, Aimee
|
|
|
|
3 |
p. 204-213
|
artikel
|
| 55 |
Update on Specifically Targeted Antiviral Therapy for Hepatitis C Infection: Progress and Pitfalls on the Road to Viral Eradication
|
Torres, Dawn McDowell
|
|
2010
|
|
3 |
p. 125-132
|
artikel
|
| 56 |
Update on Specifically Targeted Antiviral Therapy for Hepatitis C Infection: Progress and Pitfalls on the Road to Viral Eradication
|
Torres, Dawn McDowell
|
|
|
|
3 |
p. 125-132
|
artikel
|
| 57 |
Viral hepatitis and renal failure
|
Pichardo, Elsa Marisol
|
|
2009
|
|
3 |
p. 119-126
|
artikel
|
| 58 |
Viral hepatitis in African Americans
|
Reid, Andrea E.
|
|
2008
|
|
3 |
p. 120-126
|
artikel
|
| 59 |
Viral hepatitis in patients with HIV infection
|
Elsiesy, Hussien
|
|
2007
|
|
3 |
p. 103-113
|
artikel
|
| 60 |
Viral Kinetics and Duration of Hepatitis C Therapy
|
Kwo, Paul
|
|
2010
|
|
3 |
p. 140-146
|
artikel
|
| 61 |
Web alert
|
|
|
2007
|
|
3 |
p. 83
|
artikel
|
| 62 |
Web alert
|
|
|
2008
|
|
3 |
p. 93
|
artikel
|
Tijdschrift beschrijving